Jane King interviews Brian John, CEO, Jupiter Wellness
Jupiter Wellness Discusses Focus on Proprietary Patent/Patent Pending CBD Sun Care and Skin Care Brands in New Video Interview on SNN Network
LOS ANGELES, CA / ACCESSWIRE / November 30, 2020 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, is pleased to announce that SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with Brian John, CEO, and Dr. Glynn Wilson, Chairman […]
Jupiter Wellness Awarded Exclusive Distribution Agreement with Safe Sea® for the Entire Florida Market
Will Provide Distribution of Safe Sea Products via its Existing Distribution Channels for the State of Florida Through 2021 JUPITER, FL / ACCESSWIRE / November 9, 2020 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a cutting-edge wellness brand dedicated to providing multiple therapeutic and medical uses of cannabidiol (CBD), today announced the signing of an exclusive distribution agreement […]
Jupiter Wellness, Inc. Announces Closing of Initial Public Offering
JUPITER, FL / ACCESSWIRE / November 3, 2020 / Jupiter Wellness, Inc. (NASDAQ:JUPW) (the “Company”), a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products, today announced the closing of its initial public offering of 933,333 units consisting of one share of common stock […]
CaniSun a subsidiary of Jupiter Wellness Inc. to Exhibit at Surf Expo in Orlando, FL, January 8-10
The CaniSun team from CBD Brand will be showing off their fresh launched line of lip balm and sun care products at the Surf Expo 2020 in Orlando, FL, January 8th through 10th.
Jupiter Wellness Inc. Initiates Study to Investigate a Novel Cannabidiol Lotion for the Treatment of Atopic Dermatitis (Eczema)
Today Jupiter Wellness Inc. announced that it has initiated a clinical study to investigate the efficacy and safety of its proprietary CBD infused lotion formulations in the treatment of atopic dermatitis (eczema).
Douglas McKinnon Joins Jupiter Wellness Inc. as CFO
Today Jupiter Wellness Inc. announced that it has hired Douglas McKinnon as CFO. With more than 35 years’ global corporate finance experience advising companies in Mergers & Acquisitions, Initial Public Offerings and capital raises, Mr. McKinnon brings a wealth of deal experience to the Jupiter Wellness Inc. management team.
Jupiter Wellness Inc. Launches Canisun™ CBD infused Sunscreen Products
With launch of new innovative CaniSun™ suncare products, Jupiter Wellness Inc. now offers premium Sunscreen infused with Pure and Natural CBD isolate Jupiter Wellness Inc., Inc., a cutting-edge wellness brand dedicated to providing multiple therapeutic and medical uses of cannabidiol (CBD), today announced the launch of CaniSun™–a line of premium sunscreen lotions infused with pure […]
Jupiter Wellness Inc. Appoints Dr. Hector Alila to Board of Directors, Strengthening Company’s Research and Clinical Capacities
Jupiter Wellness Inc., a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products, announced today it is appointing Dr. Hector Alila to its Board of Directors. Dr. Alila, brings 30 years of demonstrated leadership in the biopharmaceutical industry and has served as the Founding President and Chief Executive Officer of Esperance Pharmaceutical Inc. for the past 13 years. His experience in guiding the Houston-based Esperance through the clinical development of novel, targeted cancer therapeutics will be key in his role with Jupiter Wellness Inc. as he helps lead the company’s innovative and nascent research into the medical and therapeutic uses of CBD in fighting various diseases.
Jupiter Wellness Inc., Inc. Appoints Dr. Glynn Wilson to CBD Board of Directors
Today Jupiter Wellness Inc., a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products, announced that it has appointed Dr. Glynn Wilson to its Board of Directors. Dr. Wilson, who previously served as the Chairman & CEO of TapImmune, Inc. prior to its merger with Marker Therapeutics, Inc., will draw from his more than 20 years of experience in the pharmaceutical industry to help expand clinical trials and research into the effectiveness of cannabidiol in the treatment of cancer as well as in combination therapy with existing cancer treatments on the market.